SCHEMBL28449581

SCHEMBL28449581

CC(=O)OC1CCN(S(=O)(=O)c2cc(C(=O)Nc3cc(F)c(F)c(F)c3)ccc2F)CC1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 13/20 0.58
▸ TP53 P04637 4/20 0.58
▸ LMNA P02545 5/20 0.56
▸ TSHR P16473 2/20 0.56
▸ HTT P42858 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ POLB P06746 2/20 0.54
▸ CYP3A4 P08684 2/20 0.51
▸ CYP2C9 P11712 2/20 0.51
▸ CYP2C19 P33261 2/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ KCNH2 Q12809 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28445685 0.90 MAPT (0.56) MAPTTP53LMNATSHRHTT
SCHEMBL17405120 0.90 MAPT (0.53) MAPTTP53LMNATSHRHTT
SCHEMBL16903295 0.90 MAPT (0.53) MAPTTP53LMNATSHRHTT
SCHEMBL28457838 0.90 MAPT (0.56) MAPTTP53LMNATSHRHTT
SCHEMBL28898452 0.90 MAPT (0.56) MAPTTP53LMNATSHRHTT
SCHEMBL28457842 0.88 MAPT (0.55) MAPTTP53LMNATSHRHTT
SCHEMBL16906295 0.88 MAPT (0.58) MAPTTP53LMNATSHRHTT
SCHEMBL28457871 0.87 LMNA (0.53) MAPTTP53LMNATSHRHTT
SCHEMBL19367498 0.87 MAPT (0.63) MAPTTP53LMNATSHRHTT
Hydrochloric Acid SCHEMBL28454395 0.86 LMNA (0.52) MAPTTP53LMNATSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109879799-B Sulfamoyl benzamide compound containing 4-carbonyloxypiperidine and preparation method thereof 浙江司太立制药股份有限公司 2020-08-11 — — CN disclosed
Send feedback